Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?
Open Access
- 14 July 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (8) , 1663-1668
Abstract
OBJECTIVE: In the U.K., people with diabetes are typically screened for retinopathy annually. However, diabetic retinopathy sometimes has a slow progression rate. We developed a simulation model to predict the likely impact of screening patients with type 2 diabetes, who have not been diagnosed with diabetic retinopathy, every 2 years rather than annually. We aimed to assess whether or not such a policy would increase the proportion of patients who developed retinopathy-mediated vision loss compared with the current policy, along with the potential cost savings that could be achieved. RESEARCH DESIGN AND METHODS: We developed a model that simulates the progression of retinopathy in type 2 diabetic patients, and the screening of these patients, to predict rates of retinopathy-mediated vision loss. We populated the model with data obtained from a National Health Service Foundation Trust. We generated comparative 15-year forecasts to assess the differences between the current and proposed screening policies. RESULTS: The simulation model predicts that implementing a 2-year screening interval for type 2 diabetic patients without evidence of diabetic retinopathy does not increase their risk of vision loss. Furthermore, we predict that this policy could reduce screening costs by ∼25%. CONCLUSIONS: Screening people with type 2 diabetes, who have not yet developed retinopathy, every 2 years, rather than annually, is a safe and cost-effective strategy. Our findings support those of other studies, and we therefore recommend a review of the current National Institute for Health and Clinical Excellence (NICE) guidelines for diabetic retinopathy screening implemented in the U.K.Keywords
This publication has 25 references indexed in Scilit:
- Decline in the Cumulative Incidence of Severe Diabetic Retinopathy in Patients With Type 1 DiabetesDiabetes Care, 2011
- Progression and Regression: Distinct Developmental Patterns of Diabetic Retinopathy in Patients With Type 2 Diabetes Treated in the Diabetes Care System West-Friesland, the NetherlandsDiabetes Care, 2011
- Diabetic retinopathy screening: a systematic review of the economic evidenceDiabetic Medicine, 2010
- Rates of Progression in Diabetic Retinopathy During Different Time PeriodsDiabetes Care, 2009
- Trends in the prevalence and incidence of diabetes in the UK: 1996–2005Journal of Epidemiology and Community Health, 2009
- Biennial eye screening in patients with diabetes without retinopathy: 10-year experienceBritish Journal of Ophthalmology, 2007
- Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathyDiabetic Medicine, 2007
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 DiabetesDiabetes Care, 2005
- UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosisDiabetologia, 2001
- Using simulation modelling for evaluating screening services for diabetic retinopathyJournal of the Operational Research Society, 2000